These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. Kristjansson S, Bjarnarson SP, Wennergren G, Palsdottir AH, Arnadottir T, Haraldsson A, Jonsdottir I. J Allergy Clin Immunol; 2005 Oct; 116(4):805-11. PubMed ID: 16210054 [Abstract] [Full Text] [Related]
5. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Simoes EA, Carbonell-Estrany X. Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448 [Abstract] [Full Text] [Related]
10. Impact of respiratory syncytial virus infection as a cause of lower respiratory tract infection in children younger than 3 years of age in Japan. Kaneko M, Watanabe J, Kuwahara M, Ueno E, Hida M, Kinoshita A, Sone T. J Infect; 2002 May; 44(4):240-3. PubMed ID: 12099731 [Abstract] [Full Text] [Related]
11. Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody. Yang DP, Zielinska E, Quiroz J, Madore D, Rappaport R. Biologicals; 2007 Jun; 35(3):183-7. PubMed ID: 17241789 [Abstract] [Full Text] [Related]
13. HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children. Mbawuike IN, Wells J, Byrd R, Cron SG, Glezen WP, Piedra PA. J Infect Dis; 2001 Mar 01; 183(5):687-96. PubMed ID: 11181144 [Abstract] [Full Text] [Related]
14. Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines. Durbin AP, Karron RA. Clin Infect Dis; 2003 Dec 15; 37(12):1668-77. PubMed ID: 14689350 [Abstract] [Full Text] [Related]
15. Lung function in prematurely born infants after viral lower respiratory tract infections. Broughton S, Sylvester KP, Fox G, Zuckerman M, Smith M, Milner AD, Rafferty GF, Greenough A. Pediatr Infect Dis J; 2007 Nov 15; 26(11):1019-24. PubMed ID: 17984809 [Abstract] [Full Text] [Related]
16. Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada. Paes B, Steele S, Janes M, Pinelli J. Curr Med Res Opin; 2009 Jul 15; 25(7):1585-91. PubMed ID: 19469698 [Abstract] [Full Text] [Related]
19. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV. Skaricic D, Traube C, De B, Joh J, Boyer J, Crystal RG, Worgall S. Virology; 2008 Aug 15; 378(1):79-85. PubMed ID: 18556039 [Abstract] [Full Text] [Related]